Therapeutic Small Molecule Program
Treatment and Reversal of Alzheimer's Disease
Pre-clinicalActive
Key Facts
Indication
Treatment and Reversal of Alzheimer's Disease
Phase
Pre-clinical
Status
Active
Company
About Aestas Pharma
Aestas Pharma is a private, pre-clinical stage biotech founded in 2016 and headquartered in Durham, North Carolina, with a presence in San Diego. The company is developing a dual-platform strategy targeting Alzheimer's disease, combining diagnostic imaging agents with therapeutic small molecules to facilitate early detection and disease-modifying treatment. Operating pre-revenue, Aestas is positioned in the high-need, high-value Alzheimer's market but faces significant scientific, clinical, and competitive risks inherent to the neurology space. Its success hinges on advancing its pipeline from pre-clinical research into human clinical trials.
View full company profile